C

C4 Therapeutics, Inc.

154 employees

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

Basic info

Industry

biotechnology research

Sectors

Health Diagnostics
biotechnology
cell biology
cell pharmacology
Therapeutics
protein chemistry
Medical
Protein Degradation

Date founded

2016

Funding rounds raised

Total raised

$25M

from 12 investors over 12 rounds

C

C4 Therapeutics, Inc. raised $25M on May 30, 2023

Investors: Betta Pharmaceuticals Co., Ltd.

C

C4 Therapeutics, Inc. raised undisclosed on August 15, 2022

Investors: Taiwania Capital

C

C4 Therapeutics, Inc. raised undisclosed on June 16, 2020

Investors: Nextech Invest, みずほ証券プリンシパルインベストメント(株), Sphera Fund, RTW Investments, LP, Perceptive Advisors, Logos Global Management, LP, RA Capital Management, L.P., Taiwania Capital and T. Rowe Price

C

C4 Therapeutics, Inc. raised $20M on June 16, 2020

Investors: Perceptive Advisors

FAQ